PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Insights+: The US FDA New Drug Approvals in February 2021

Insights+: The US FDA New Drug Approvals in February 2021

March 18, 2021

Merck Collaborates with Amathus Therapeutics to Develop Treatments for Neurodegenerative Diseases

Merck Collaborates with Amathus Therapeutics to Develop Treatments for Neurodegenerative Diseases

March 18, 2021

WuXi Biologics to Acquire Pfizer's Biologics Manufacturing Facilities in China

WuXi Biologics to Acquire Pfizer's Biologics Manufacturing Facilities in China

March 18, 2021

Merck Signs a Five-Year Agreement with M2GEN to Advance Cancer Therapies

Merck Signs a Five-Year Agreement with M2GEN to Advance Cancer Therapies

March 18, 2021

FSD Pharma Signs a License Agreement with Innovet to Develop Veterinary Drugs for Gastro-Intestinal Diseases in Dogs and Cats

FSD Pharma Signs a License Agreement with Innovet to Develop Veterinary Drugs for Gastro-Intestinal Diseases in Dogs and Cats

March 18, 2021

Merck's Keytruda (pembrolizumab) Receives the EC's Approval in Adults & Pediatric patients with R/R cHL

Merck's Keytruda (pembrolizumab) Receives the EC's Approval in Adults & Pediatric patients with R/R cHL

March 18, 2021

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us